Significant Ownership of David Lazar

Signature - Title
/s/ David E. Lazar - David E. Lazar
Location
Panama City
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by David Lazar.

Notify me when David Lazar files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of David Lazar

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MINM FiEE, Inc. Common Stock, $0.01 par value 35% $308,248 2,802,254 -63% Lazar David E. 18 Feb 2025
MTNB Matinas BioPharma Holdings, Inc. Common Stock, par value $0.0001 per share 9.8% $517,750 545,000 Lazar David E. 15 Aug 2025
UUU Universal Safety Products, Inc. Common Stock, par value $0.01 per share 6.8% $799,184 156,396 Lazar David E. 16 Jan 2026
KALA KALA BIO, Inc. Common Stock, $0.001 par value 5.2% $27,522,000 49,500,000 David E. Lazar 30 Jan 2026
NBY NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value 5% $36,028,320 +$27,556,589 6,388,000 +325% David E. Lazar 21 Oct 2025
CYCC Cyclacel Pharmaceuticals, Inc. Common Stock, $0.001 par value 0% $0 -$41,481 0 -100% Lazar David E. 05 Aug 2025

Schedules 13D/G Reported by David Lazar:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.